Daryl Nounnan, MD
Family Practice · Freedom
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 3 carriers
- Offices
- 5
Offices
5 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Plans that list them
14 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Nounnan’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A66931 · Current
Licensed to practise in California · since 1998 · expires 2028-07-31 · University of California, Davis School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$52,717
Medicare paid this office $52,717 for 535 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 406 | $37,398 | $89 |
| Short return visit (20+ min) | 92 | $5,473 | $59 |
| Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | 22 | $3,075 | $140 |
| Long return visit (40+ min) | 19 | $2,780 | $146 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 12 | $603 | $50 |
See all 8 services
| Return visit (30+ min) | 406 | $37,398 | $89 |
| Short return visit (20+ min) | 92 | $5,473 | $59 |
| Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | 22 | $3,075 | $140 |
| Long return visit (40+ min) | 19 | $2,780 | $146 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 12 | $603 | $50 |
| Injection of drug or substance under skin or into muscle | 13 | $200 | $13 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 12 | $194 | $16 |
| Automated urinalysis test | 74 | $165 | $2 |
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
Who their Medicare patients are
535 Original Medicare patients in 2024. Average age 75 · Under 65 6% · 85 and older 12% · Women 64% · Also on Medicaid 14% · Health risk score 1.03. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 61% · Atrial fibrillation 20% · Diabetes 19% · Depression 19% · Coronary heart disease 18% · Chronic kidney disease 17% · Cancer 15% · Heart failure 13% · COPD 9% · Stroke 4% · Dementia 2%.
The office billed $220,205, Medicare allowed $79,223 and paid $52,717; for 781 services of 39 kinds; $258 of it was for drugs given in the office and $52,459 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 535 | 781 | 75 | 1.03 | $220,205 | $52,717 |
| 2023 | 659 | 885 | 75 | 0.99 | $251,648 | $66,655 |
| 2022 | 655 | 884 | 75 | 1.05 | $235,169 | $66,456 |
| 2021 | 583 | 897 | 74 | 0.92 | $212,960 | $64,012 |
| 2020 | 474 | 675 | 74 | 1.08 | $175,835 | $41,263 |
| 2019 | 647 | 918 | 74 | 1.10 | $237,086 | $57,838 |
| 2018 | 742 | 1,101 | 74 | 1.05 | $265,831 | $62,843 |
| 2017 | 697 | 950 | 73 | 1.11 | $240,505 | $55,496 |
| 2016 | 611 | 1,106 | 74 | 1.11 | $209,794 | $51,404 |
| 2015 | 496 | 723 | 72 | 0.96 | $168,352 | $43,142 |
| 2014 | 652 | 968 | 73 | 1.02 | $191,258 | $48,318 |
| 2013 | 490 | 752 | 73 | 1.01 | $152,956 | $38,012 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Return visit (30+ min) | 431 | $42,860 | $96 |
| Short return visit (20+ min) | 191 | $12,717 | $66 |
| Long return visit (40+ min) | 18 | $2,834 | $157 |
| Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | 12 | $1,677 | $140 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 21 | $1,056 | $50 |
| New patient visit (30+ min) | 13 | $987 | $76 |
| Automated urinalysis test | 76 | $167 | $2 |
2022: 6 services
| Return visit (30+ min) | 433 | $43,880 | $100 |
| Short return visit (20+ min) | 192 | $13,233 | $68 |
| Long return visit (40+ min) | 21 | $3,616 | $172 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 29 | $1,471 | $51 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 11 | $180 | $16 |
| Automated urinalysis test | 77 | $173 | $2 |
2021: 7 services
| Return visit (30+ min) | 421 | $44,383 | $102 |
| Short return visit (20+ min) | 115 | $8,632 | $74 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 65 | $3,386 | $51 |
| Long return visit (40+ min) | 18 | $2,890 | $161 |
| Injection of drug or substance under skin or into muscle | 19 | $253 | $13 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 13 | $215 | $17 |
| Automated urinalysis test | 83 | $194 | $2 |
2020: 5 services
| Return visit (30+ min) | 355 | $28,084 | $77 |
| Long return visit (40+ min) | 42 | $5,098 | $121 |
| Short return visit (20+ min) | 56 | $2,779 | $50 |
| Administration of influenza virus vaccine | 11 | $224 | $20 |
| Automated urinalysis test | 59 | $134 | $2 |
2019: 6 services
| Return visit (30+ min) | 474 | $40,988 | $83 |
| Short return visit (20+ min) | 128 | $6,857 | $52 |
| Long return visit (40+ min) | 22 | $2,319 | $105 |
| Injection of drug or substance under skin or into muscle | 14 | $238 | $14 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 13 | $211 | $16 |
| Automated urinalysis test | 72 | $183 | $2 |
2018: 9 services
| Return visit (30+ min) | 556 | $44,195 | $76 |
| Short return visit (20+ min) | 123 | $6,541 | $52 |
| Long return visit (40+ min) | 38 | $4,634 | $122 |
| New patient visit (30+ min) | 13 | $974 | $75 |
| Injection of drug or substance under skin or into muscle | 19 | $375 | $17 |
| Automated urinalysis test | 112 | $309 | $3 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 16 | $251 | $16 |
| Inhalation treatment for airway obstruction or sputum production | 11 | $184 | $15 |
| Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 11 | $1 | None |
2017: 6 services
| Return visit (30+ min) | 477 | $36,137 | $72 |
| Short return visit (20+ min) | 162 | $8,715 | $53 |
| Long return visit (40+ min) | 25 | $2,876 | $115 |
| New patient visit (30+ min) | 28 | $1,634 | $58 |
| Automated urinalysis test | 65 | $207 | $3 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 11 | $137 | $12 |
2016: 7 services
| Return visit (30+ min) | 428 | $35,878 | $79 |
| Short return visit (20+ min) | 121 | $6,077 | $48 |
| Long return visit (40+ min) | 43 | $4,478 | $104 |
| New patient visit (30+ min) | 18 | $1,414 | $79 |
| Injection of drug or substance under skin or into muscle | 20 | $509 | $21 |
| Automated urinalysis test | 44 | $132 | $3 |
| Injection, ceftriaxone sodium, per 250 mg | 12 | $32 | None |
2015: 6 services
| Return visit (30+ min) | 247 | $22,237 | $85 |
| Short return visit (20+ min) | 203 | $11,622 | $54 |
| Long return visit (40+ min) | 21 | $2,521 | $120 |
| New patient visit (30+ min) | 25 | $2,052 | $82 |
| Short return visit | 13 | $466 | $33 |
| Automated urinalysis test | 69 | $210 | $3 |
2014: 7 services
| Return visit (30+ min) | 260 | $22,212 | $81 |
| Short return visit (20+ min) | 322 | $16,966 | $50 |
| Long return visit (40+ min) | 20 | $2,235 | $112 |
| New patient visit (30+ min) | 31 | $2,139 | $69 |
| Automated urinalysis test | 82 | $249 | $3 |
| Injection, ceftriaxone sodium, per 250 mg | 13 | $26 | None |
| Injection, ketorolac tromethamine, per 15 mg | 13 | $14 | None |
2013: 6 services
| Return visit (30+ min) | 185 | $15,258 | $79 |
| Short return visit (20+ min) | 236 | $12,629 | $51 |
| Long return visit (40+ min) | 26 | $2,743 | $106 |
| New patient visit (30+ min) | 25 | $1,648 | $66 |
| Short return visit | 19 | $576 | $30 |
| Automated urinalysis test | 53 | $168 | $3 |
Medicaid work
$9,392 in 2024
Medicaid paid $9,392 for 112 billed services this clinician did in 2024, up to 18 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 98 | $8,298 |
| Short return visit (20+ min) | 14 | $1,093 |
| 2024 | 112 | 2 | 18 | $9,392 |
| 2023 | 408 | 2 | 36 | $34,329 |
| 2022 | 346 | 2 | 33 | $31,179 |
| 2021 | 171 | 2 | 22 | $13,400 |
| 2020 | 133 | 2 | 36 | $10,604 |
| 2019 | 305 | 2 | 33 | $21,296 |
| 2018 | 256 | 2 | 31 | $16,256 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 313 | $27,399 |
| Short return visit (20+ min) | 95 | $6,929 |
2022
| Return visit (30+ min) | 256 | $24,556 |
| Short return visit (20+ min) | 90 | $6,622 |
2021
| Return visit (30+ min) | 134 | $10,763 |
| Short return visit (20+ min) | 37 | $2,637 |
2020
| Return visit (30+ min) | 117 | $9,762 |
| Short return visit (20+ min) | 16 | $842 |
2019
| Return visit (30+ min) | 284 | $19,867 |
| Short return visit (20+ min) | 21 | $1,429 |
2018
| Return visit (30+ min) | 220 | $13,884 |
| Short return visit (20+ min) | 36 | $2,372 |
Drugs they prescribed that Part D paid
$3,447
Pharmacies billed $3,447 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (11 of 353) in 2024. Above the middle of the specialty; the typical family practice clinician is at 2%.
324 generic and fewer than 11 brand-name prescriptions · $3,447 in drug cost · 172 antibiotic prescriptions to 159 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Amoxicillin-Clavulanate Potass | 42 | $275 | $7 |
| Cephalexin | 40 | $176 | $4 |
| Doxycycline Hyclate | 20 | $133 | $7 |
| Mupirocin | 16 | $58 | $3 |
| Azithromycin | 14 | $45 | $3 |
See all 8 drugs
| Amoxicillin-Clavulanate Potass | 42 | $275 | $7 |
| Cephalexin | 40 | $176 | $4 |
| Doxycycline Hyclate | 20 | $133 | $7 |
| Mupirocin | 16 | $58 | $3 |
| Azithromycin | 14 | $45 | $3 |
| Sulfamethoxazole-Trimethoprim | 15 | $45 | $3 |
| Prednisone | 11 | $35 | $3 |
| Paxlovid | 19 | $0 | $0 |
Year by year
| 2024 | 353 | 285 | 3% (11) | None | $3,447 |
| 2023 | 386 | 302 | None | 6% | $8,739 |
| 2022 | 362 | 288 | 4% (15) | 4% | $7,609 |
| 2021 | 275 | 210 | 4% (12) | 10% | $8,379 |
| 2020 | 308 | 208 | None | 10% | $8,198 |
| 2019 | 372 | 270 | 3% (11) | 10% | $8,291 |
| 2018 | 364 | 284 | None | 8% | $6,445 |
| 2017 | 383 | 279 | 6% (22) | None | $11,150 |
| 2016 | 337 | 247 | 6% (21) | None | $6,225 |
| 2015 | 250 | 193 | 8% (19) | None | $6,016 |
| 2014 | 307 | 222 | 9% (26) | 14% | $8,119 |
| 2013 | 223 | 173 | 9% (19) | 15% | $5,075 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 11 drugs
| Amoxicillin-Clavulanate Potass | 36 | $339 | $9 |
| Cephalexin | 41 | $286 | $7 |
| Mupirocin | 20 | $267 | $13 |
| Triamcinolone Acetonide | 14 | $261 | $19 |
| Doxycycline Hyclate | 21 | $255 | $12 |
| Paxlovid (Eua) | 22 | $220 | $10 |
| Nystatin | 13 | $199 | $15 |
| Azithromycin | 18 | $96 | $5 |
| Prednisone | 16 | $64 | $4 |
| Amoxicillin | 11 | $45 | $4 |
| Sulfamethoxazole-Trimethoprim | 13 | $40 | $3 |
2022: 10 drugs
| Doxycycline Hyclate | 18 | $320 | $18 |
| Diclofenac | 12 | $294 | $25 |
| Amoxicillin-Clavulanate Potass | 28 | $273 | $10 |
| Paxlovid (Eua) | 24 | $233 | $10 |
| Doxycycline Monohydrate | 14 | $171 | $12 |
| Cephalexin | 30 | $163 | $5 |
| Sulfamethoxazole-Trimethoprim | 27 | $123 | $5 |
| Mupirocin | 11 | $104 | $9 |
| Hydrocodone-Acetaminophen | 11 | $50 | $5 |
| Prednisone | 17 | $46 | $3 |
2021: 8 drugs
| Amoxicillin-Clavulanate Potass | 25 | $332 | $13 |
| Diclofenac | 11 | $313 | $28 |
| Mupirocin | 12 | $124 | $10 |
| Triamcinolone Acetonide | 11 | $111 | $10 |
| Cephalexin | 16 | $101 | $6 |
| Sulfamethoxazole-Trimethoprim | 18 | $86 | $5 |
| Famotidine | 12 | $71 | $6 |
| Prednisone | 17 | $55 | $3 |
2020: 9 drugs
| Cephalexin | 34 | $163 | $5 |
| Triamcinolone Acetonide | 19 | $159 | $8 |
| Doxycycline Hyclate | 12 | $153 | $13 |
| Amoxicillin-Clavulanate Potass | 18 | $140 | $8 |
| Mupirocin | 14 | $100 | $7 |
| Famotidine | 12 | $93 | $8 |
| Amoxicillin | 18 | $87 | $5 |
| Azithromycin | 11 | $59 | $5 |
| Prednisone | 14 | $59 | $4 |
2019: 9 drugs
| Ventolin Hfa | 12 | $676 | $56 |
| Doxycycline Hyclate | 22 | $363 | $17 |
| Cephalexin | 60 | $327 | $5 |
| Amoxicillin-Clavulanate Potass | 20 | $235 | $12 |
| Azithromycin | 21 | $153 | $7 |
| Mupirocin | 14 | $126 | $9 |
| Amoxicillin | 18 | $122 | $7 |
| Sulfamethoxazole-Trimethoprim | 11 | $44 | $4 |
| Prednisone | 13 | $36 | $3 |
2018: 9 drugs
| Cephalexin | 48 | $252 | $5 |
| Amoxicillin-Clavulanate Potass | 26 | $248 | $10 |
| Doxycycline Hyclate | 13 | $228 | $18 |
| Azithromycin | 29 | $175 | $6 |
| Mupirocin | 12 | $174 | $14 |
| Amoxicillin | 26 | $137 | $5 |
| Ciprofloxacin | 21 | $102 | $5 |
| Prednisone | 18 | $77 | $4 |
| Naproxen | 18 | $46 | $3 |
2017: 10 drugs
| Amoxicillin-Clavulanate Potass | 21 | $243 | $12 |
| Azithromycin | 31 | $239 | $8 |
| Cephalexin | 39 | $183 | $5 |
| Doxycycline Hyclate | 14 | $159 | $11 |
| Ciprofloxacin | 20 | $119 | $6 |
| Amoxicillin | 19 | $118 | $6 |
| Mupirocin | 11 | $101 | $9 |
| Ranitidine | 11 | $74 | $7 |
| Prednisone | 13 | $73 | $6 |
| Hydrocodone-Acetaminophen | 18 | $54 | $3 |
2016: 9 drugs
| Doxycycline Hyclate | 18 | $458 | $25 |
| Cephalexin | 58 | $337 | $6 |
| Nitrofurantoin Mono-Macro | 11 | $231 | $21 |
| Amoxicillin-Clavulanate Potass | 14 | $138 | $10 |
| Hydrocodone-Acetaminophen | 18 | $129 | $7 |
| Azithromycin | 15 | $122 | $8 |
| Amoxicillin | 17 | $101 | $6 |
| Mupirocin | 11 | $97 | $9 |
| Prednisone | 11 | $39 | $4 |
2015: 6 drugs
| Azithromycin | 20 | $176 | $9 |
| Amoxicillin-Clavulanate Potass | 16 | $158 | $10 |
| Tobramycin | 14 | $130 | $9 |
| Ciprofloxacin | 22 | $129 | $6 |
| Cephalexin | 24 | $109 | $5 |
| Hydrocodone-Acetaminophen | 15 | $94 | $6 |
2014: 8 drugs
| Doxycycline Hyclate | 17 | $599 | $35 |
| Nitrofurantoin Mono-Macro | 14 | $323 | $23 |
| Amox Tr-Potassium Clavulanate | 21 | $317 | $15 |
| Cephalexin | 31 | $170 | $5 |
| Hydrocodone-Acetaminophen | 22 | $162 | $7 |
| Ranitidine | 18 | $135 | $7 |
| Azithromycin | 14 | $114 | $8 |
| Ciprofloxacin | 21 | $92 | $4 |
2013: 5 drugs
| Nitrofurantoin Mono-Macro | 21 | $527 | $25 |
| Azithromycin | 18 | $185 | $10 |
| Cephalexin | 18 | $113 | $6 |
| Hydrocodone-Acetaminophen | 15 | $80 | $5 |
| Ciprofloxacin | 16 | $70 | $4 |
Professional record
- NPI
- 1134109671
- Licence
- CA A66931California A66931: Current · expires 2028-07-31
- Trained
- University of California, Davis School of Medicine, 1995
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 2025 Soquel Ave, Santa Cruz, CA, 95062
- NPI first listed
- 2006-01-19
- NPI last updated
- 2011-09-15
This is when the NPI record was last certified, not a medical board exam.